azathioprine has been researched along with Placental Insufficiency in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Placental Insufficiency: Failure of the PLACENTA to deliver an adequate supply of nutrients and OXYGEN to the FETUS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, G | 1 |
Crispin, P | 1 |
Cherian, M | 1 |
Dahlstrom, JE | 1 |
Sethna, FF | 1 |
Kaye, G | 1 |
Pavli, P | 1 |
Subramaniam, K | 1 |
1 other study available for azathioprine and Placental Insufficiency
Article | Year |
---|---|
Placental involvement by non-Hodgkin lymphoma in a Crohn disease patient on long-term thiopurine therapy.
Topics: Adult; Azathioprine; Crohn Disease; Female; Fetal Death; Humans; Lymphoma, Non-Hodgkin; Placenta; Pl | 2016 |